Elinza Pharmaceuticals Private Limited
About Elinza Pharmaceuticals Private Limited
Data last updated:
Elinza Pharmaceuticals Private Limited is a private limited company based in Chandigarh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 06 April 2022.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U51909CH2022PTC044296. Its GSTIN is 04AAGCE9761R1ZV (Chandigarh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Vikram Khungar and Raj Khurana.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. 4 – A, First Floor, Chandigarh, India – 160102.
As per the financials filed for FY 2025, the company reported a revenue of ₹14.42 Lakh, a growth of 17% compared to the previous year. For the same year it recorded a net profit of ₹7,362 (net margin 0.5%) and EBITDA of ₹30,066 (EBITDA margin 2.1%).
Company details
Contact details
Elinza Pharmaceuticals Private Limited's registered office is in Chandigarh, Chandigarh.
- Registered AddressPlot No. 4 – A, First Floor, Chandigarh, India – 160102
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Elinza Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Elinza Pharmaceuticals Private Limited, buy the company report.
Financials of Elinza Pharmaceuticals Private Limited
FY 2025 filings availableElinza Pharmaceuticals Private Limited reported revenue of ₹14.42 Lakh (up 17% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 17% in the latest year. EBITDA fell 57% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹30,066 | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹7,362 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 2.1% | ||
| Net Profit Margin | 0.5% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Elinza Pharmaceuticals Private Limited, buy the company report.
Board of directors of Elinza Pharmaceuticals Private Limited
Elinza Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vikram Khungar Also directs: Eswar Healthcare LLP, Eswar Therapeutics Private Limited | Director | 06 Apr 2022 | 4 Years 6 Months | Current |
| Raj Khurana Also directs: Eswar Therapeutics Private Limited | Director | 25 Nov 2024 | 1 Years 11 Months | Current |
Peer comparison
Elinza Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Herbonicz Ind Private Limited | ₹14.43 Lakh (FY 2024) | 16.0% | Chennai, Tamil Nadu, India | |||
| Elinza Pharmaceuticals Private Limitedthis company | ₹14.42 Lakh (FY 2025) | ₹7,362 | 0.5% | 17.0% | Chandigarh, India | |
| Orvietan Pharmaceuticals Private Limited | ₹14.38 Lakh (FY 2024) | -25.0% | Hyderabad, Telangana, India | |||
| Metascan Pharma Private Limited | ₹14.38 Lakh (FY 2025) | 5.0% | Ranchi, Jharkhand, India |
To see the full peer comparison of Elinza Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Elinza Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Elinza Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Elinza Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 04AAGCE9761R1ZV | Chandigarh | Active | 01 Jun 2022 |
To see the full GST registrations and return filing status of Elinza Pharmaceuticals Private Limited, buy the company report.
Recent activity
Elinza Pharmaceuticals Private Limited has 4 board changes on record since 2022: 2 appointments and 2 cessations. The latest: Raj Khurana ceased to be Additional Director on 29 Sep 2025.
Frequently asked questions
Elinza Pharmaceuticals is an active private limited company based in Chandigarh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 06 April 2022 (4+ years old) and is registered under CIN U51909CH2022PTC044296.
Elinza Pharmaceuticals has 2 current directors:
- Vikram Khungar - Director
- Raj Khurana - Director
The latest financial statements of Elinza Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The GSTIN of Elinza Pharmaceuticals is 04AAGCE9761R1ZV, registered in Chandigarh.
The CIN (Corporate Identification Number) of Elinza Pharmaceuticals is U51909CH2022PTC044296. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Elinza Pharmaceuticals was incorporated on 06 April 2022, making it 4+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Elinza Pharmaceuticals by revenue are Herbonicz Ind Private Limited, Orvietan Pharmaceuticals Private Limited, Metascan Pharma Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Raj Khurana ceased to be Additional Director on 29 Sep 2025. Dipty Manchanda ceased to be Director on 14 Dec 2024. Raj Khurana was appointed as Director on 25 Nov 2024. Elinza Pharmaceuticals has 4 board changes on record in total.
The registered office of Elinza Pharmaceuticals is at Plot No. 4 – A, First Floor, Chandigarh, India – 160102.
Elinza Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Elinza Pharmaceuticals can be reached at its registered office: Plot No. 4 – A, First Floor, Chandigarh, India – 160102.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
